CRISPR Tx reported reductions in triglycerides and LDL cholesterol of more than 80% after a single dose of its in vivo liver editing prospect CTX310.

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.

CRISPR investors are looking for the big home-run hitters, while those with more modest scientific goals are, more often than not, the ones who deliver.

Researchers find CRISPR is capable of even more than we thought Date: May 16, 2025 Source: Rockefeller University Summary: Newly discovered weapons of bacterial self-defense take different ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 gene-editing tool to spiders. Following the genetic modification, the spiders ...

The Center for Pediatric CRISPR Cures will start by creating custom therapies for eight patients with rare immune or metabolic genetic diseases.

CRISPR uncovers gene that supercharges vitamin D—and stops tumors in their tracks Scientists hail key gene with promising ‘new avenues’ for precision medicine through CRISPR/Cas9.

New CRISPR tool enables more seamless gene editing — and improved disease modeling Yale scientists have developed a CRISPR technology that can assess genetic interactions on a host of immunological ...

Researchers in Lithuania present the molecular structure of a new, more-versatile CRISPR system for gene editing.